Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,111,208
+$20,921,212 QoQ
Shares Held
2,279,451
+41.6% QoQ
Ownership
3.09%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Derivatives in INVA
reported options exposure · as of Sep 30, 2021CallValue
$3,342,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. INVA ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in INVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,111,208 | 2,279,451 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,189,996 | 1,610,305 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,953,998 | 1,641,315 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $39,966,081 | 1,989,352 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,386,913 | 1,676,057 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,950,635 | 400,613 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,469,452 | 76,098 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $372,001 | 22,683 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $269,610 | 17,691 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $4,873,016 | 375,136 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,145,061 | 1,032,605 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,440,385 | 1,105,812 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,277,567 | 2,134,156 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,071,114 | 2,503,972 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,566,549 | 1,325,647 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,766,145 | 1,176,545 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,604,279 | 1,252,422 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,342,000 | 200,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $21,674,708 | 1,297,110 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,023,000 | 300,000 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $9,352,871 | 697,455 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $165,866 | 13,880 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $746,527 | 71,438 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||